ArticleInternational journal of medical sciences2025
Population Pharmacokinetic-pharmacodynamic Model Analysis of Dapagliflozin for HbA1c-lowering Effects in Japanese Patients with Type 2 Diabetes Mellitus using Long-term Real-world Data.
Shinji Kobuchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.